Current understanding of androgenetic alopecia. Part I: Etiopathogenesis

European Journal of Dermatology

Volumn 10, Issue 4, 2000, Pages 319-326

  Hoffmann, Rolf ^a   Happle, Rudolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Androgen metabolism; Androgens; Hair; Hair loss; Inheritance; Treatment)

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROSTANOLONE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ANDROGEN METABOLISM; FEMALE; GENETIC PREDISPOSITION; HAIR; HAIR GROWTH; HAIR LOSS; HUMAN; MALE; MALE TYPE ALOPECIA; NONHUMAN; REVIEW;

17-HYDROXYSTEROID DEHYDROGENASES; ALOPECIA; ANDROGENS; ANIMALS; AROMATASE; ARYLSULFATASES; CHOLESTENONE 5 ALPHA-REDUCTASE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAIR FOLLICLE; HUMANS; LINKAGE (GENETICS); MULTIENZYME COMPLEXES; MUTATION; OXIDOREDUCTASES; POLYMORPHISM, GENETIC; PROGESTERONE REDUCTASE; RECEPTORS, ANDROGEN; SEX CHROMOSOME ABERRATIONS; STEROID ISOMERASES; STERYL-SULFATASE; X CHROMOSOME;

EID: 0034090473     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. 1. Braun-Falco O, Bergner T. Die androgenetische Alopezie des Mannes. Neuere Entwicklungen. Hautarzt 1989; 40: 669-78.
2. 2. Bergfeld WF. Androgenetic alopecia: an autosomal dominant disorder. Am J Med 1995; 98: 95S-8S.
3. 3. Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5alpna-reductase genes. J Invest Dermatol 1998; 110: 849-53.
4. 4. Kuster W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 1984; 11: 921-26.
5. 5. Sreekumar GP, Pardinas J, Wong CQ, Whiting D, Katz HI, Price V, Zlotogorski A, Roberts J, Clark BC, Stenn K, Parimoo S. Serum androgens and genetic linkage analysis in early onset androgenetic alopecia. J Invest Dermatol 1999; 113: 277-9.
6. 6. Carey AH, Chan KL, Short F, White D, Williamson R, Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 1993; 38: 653-58.
7. 7. Ferriman D, Purdie AW. The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) 1979; 11: 291 -300.
8. 8. Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, Conway GS, White D, Todd JA, Franks S, Williamson R. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997; 349: 986-90.
9. 9. Sawaya ME, Shalita AR. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne [In Process Citation]. J Cutan Med Surg 1998; 3: 9-15.
10. 10. König A, Happle R, Tchicherina E, Schäfer JR, Sokolowski P, Köhler W, Hoffmann R. An X-linked gene involved in androgenetic alopecia: a lesson to be learned from adernoleukodystrophy. Dermatology (in press) 2000.
11. 11. Rhodes L, Harper J, Uno H, Gaito G, Audette-Arruda J, Kurata S, Berman C, Primka R, Pikounis B. The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaca arctoides). J Clin Endocrinol Metab 1994; 79: 991-6.
12. 12. Ohuchi A, Mitsui S, Hotta M, Hattori M, Tsuboi R, Ogawa H. Involvement of androgens in vivo and in vitro during the dorsal noir growth of castrated rat, in Neste va D, Randall V (eds): Hair research for the next millennium. Amsterdam, Elsevier, 1996, p. 293-6.
13. 13. Kondo S, Hozumi Y: Transplantation of vellus hair in male pattern baldness to nude mice., in Neste va D, Randall V, eds. Hair research for the next millennium. Amsterdam, Elsevier, 1996, p. 315-8.
14. 14. Van Neste D, de Brouwer B, Tételin C, Bonfils A: Testosterone conditioned nude mice: an improved model for experimental monitoring of human hair production by androgen dependent balding scalp grafts., in Neste va D, Randall V, eds., Hair research for the next millennium. Amsterdam, Elsevier, 1996, p. 319-22.
15. 15. Matias JR, Orentreich N. The effect of testosterone, cyproterone acetate, and minoxidil on hair loss in the androchronogenetic alopecia mouse. Clin Dermatol 1988; 6: 169-76.
16. 16. Matias JR, Malloy V, Orentreich N. Animal models of androgen-dependent disorders of the pilosebaceous apparatus. 1. The androchronogenefic alopecia (AGA) mouse as a model for male-pattern baldness. Arch Dermatol Res 1989; 281: 247-53.
17. 17. Hamilton JB. Male hormone stimulation as a prerequisite and an incitement in common baldness. Am J Anat 1942; 71: 451-3.
18. 18. Balducci R, Ghirri P, Brown TR, Bradford S, Boldrini A, Boscherini B, Sciarra F, Toscano V. A clinician looks at androgen resistance. Steroids 1996; 61: 205-11.
19. 19. Takashima I, Montagna W. Studies of common baldness of the stump-tailed macaque (Macaca speciosa). VI. The effect of testosterone on common baldness. Arch Dermatol 1971; 103: 527-34.
20. 20. Obana N, Chang C, Uno H. Inhibition of hair growth by testosterone in the presence of dermal papilla cells from the frontal bald scalp of the postpubertal stumptailed macaque. Endocrinology 1997; 138: 356-61.
21. 21. Metcalf BW, Levy MA, Holt DA. Inhibitors of steroid 5 alpha-reductase in benign prostatic hyperplasia, male pattern baldness and acne. Trends Pharmacol Sci 1989; 10: 491-5.
22. 22. Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109: 296-300.
23. 23. Jahoda CA. Cellular and developmental aspects of androgenetic alopecia. Exp Dermatol 1998; 7: 235-48.
24. 24. Van Scott EJ, Ekel TM. Goemetric relations ships between the matrix of the hair bulb and its dermal papilla in normal and alopecix scalp. J Invest Dermatol 1958; 31: 281-7.
25. 25. Van Scott EJ, Ekel TM, Auerbach R. Determinants of rate and kinetics of cell division in human scalp hair. J Invest Dermatol 1963; 41: 281-7.
26. 26. Elliot K, Stephenson TJ, Messenger AG. Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses. J Invest Dermatol 1999; 113: 873-7.
27. 27. Sperling LC, Heimer WL Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. I. J Am Acad Dermatol 1993; 28: 669-83.
28. 28. Sawaya ME, Honig LS, Garland LD, Hsia SL. delta 5-3 beta-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness. J Invest Dermatol 1988; 91: 101-5.
29. 29. Ehrmann DA, Rosenfield RL. Clinical review 10: An endocrinologic approach to the patient with hirsutism. J Clin Endocrinol Metab 1990; 71: 1-4.
30. 30. White PC. Genetic diseases of steroid metabolism. Vitam Horm 1994; 49: 131-95.
31. 31. Ishihara F, Komatsu M, Yamada T, Aizawa T, Ichikawa K, Takasu N, Komiya I. Role of dehydroepiandrosterone and dehydroepiandrosterone sulfate for the maintenance of axillary hair in women. Horm Metab Res 1993; 25: 34-6.
32. 32. Steinberger E, Smith KD, Rodriguez-Rigau U. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women. J Clin Endocrinol Metab 1984; 59: 471-7.
33. 33. Kasick JM, Bergfeld WF, Steck WD, Gupta MK. Adrenal androgenic female-pattern alopecia: sex hormones and the balding woman. Cleve Clin Q 1983; 50: 111-22.
34. 34. Pitts RL. Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men. J Am Acad Dermatol 1987; 16: 571-3.
35. 35. Rheaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydroqenase gene. Nat Genet 1992; 1: 239-45.
36. 36. Morel Y, Mebarki F, Rheaume E, Sanchez R, Forest MG, Simard J. Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency. Steroids 1997; 62: 176-84.
37. 37. Hodgins MB, Murad S, Simpson NB. A search for variation in hair follicle androgen metabolism which might be linked to male pattern baldness. Br J Dermatol 1985; 113: 794 (abstr.).
38. 38. Andersson S, Moghrabi N. Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 1997; 62: 143-7.
39. 39. Nowakowski H, Lenz W. Genetic aspects of male hypogonadism. Prog Horm REs 1961; 17: 53-89.
40. 40. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974; 186: 1213-5.
41. 41. Thigpen AE, Davis DL, Milatovich A Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 1992; 90: 799-809.
42. 42. Sinnecker GH, Hiort O, Dibbelt L, Albers N, Dorr HG, Hauss H, Heinrich U, Hemminghaus M, Hoepffner W, Holder M, Schnabel D, Kruse K. Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. Am J Med Genet 1996; 63: 223-30.
43. 43. Sawaya ME. Steroid chemistry and hormone controls during the hair follicle cycle. Ann N Y Acad Sci 1991; 642: 376-83; discussion 383-74.
44. 44. Chen W, Zouboulis CC, Orfanos CE. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 1996; 193: 177-84.
45. 45. Dijkstra AC, Vermeesch-Markslag AM, Vromans EW, Happle R, van de Kerkhof PC, Zwanenburg B, Vas F, Vermorken AJ. Substrate specific sulfatase activity from hair follicles in recessive X-linked ichthyosis. Acta Derm Venereol 1987; 67: 369-76.
46. 46. Dumont M, Van LT, Dupont E, Pelletier G, Labrie F. Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J Invest Dermatol 1992; 99: 415-21.
47. 47. Fazekas AG, Lanthier A. Metabolism of androgens by isolated human beard hair follicles. Steroids 1971; 18: 367-79.
48. 48. Hay JB, Hodgins MB. Distribution of androgen metabolizing enzymes in isolated tissues of human forehead and axillary skin. J Endocrinol 1978; 79: 29-39.
49. 49. Courchay G, Boyera N, Bernard BA, Mahe Y. Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit. Skin Pharmacol 1996; 9: 169-76.
50. 50. Takashima I, Adachi K, Montagna W. Studies of common baldness in the stumptailed macaque. IV. In vitro metabolism of testosterone in the hair follicles. J Invest Dermatol 1970; 55: 329-34.
51. 51. Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones. I. Testerone metabolism in isolated hairs. J Clin Endocrinol Metab 1974; 38: 811-9.
52. 52. Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones. II. Androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab 1974; 39: 1012-9.
53. 53. Takayasu S, Adachi K. The conversion of testosterone to 17-hydroxy-5-androstan-3-one (dihydrotestosterone) by human hair follicles. J Clin Endocrinol Metab 1972; 34: 1098-101.
54. 54. Takayasu S, Wakimoto H, Itami S, Sano S. Activity of testosterone 5 alpha-reductase in various tissues of human skin. J Invest Dermatol 1980; 74: 187-91.
55. 55. Fazekas AG, Sandor T. Metabolism of androgens by isolated human hair follicles. J Steroid Biochem 1972; 3: 485-91.
56. 56. Schmidt JA, Schweikert HU. Testosterone and epitestosterone metabolism of single hairs in 5 patients with 5 alpha-reductase-deficiency. Acta Endocrinol (Copenh) 1986; 113: 588-92.
57. 57. Thornton MJ, Hamada K, Laing I, Messenger AG, Randall VA. Metabolism of testosterone by cultured dermal papilla cells from human beard, pubic, and scalp hair follicles. Ann N Y Acad Sci 1991; 642: 452-3.
58. 58. Thornton MJ, Laing I, Hamada K, Messenger AG, Randall VA. Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells. Clin Endocrinol (Oxf) 1993; 39: 633-9.
59. 59. Randall VA, Thornton MJ, Hamada K, Messenger AG. Mechanism of androgen action in cultured dermal papilla cells derived from human hair follicles with varying responses to androgens in vivo. J Invest Dermatol 1992; 98: 86S-91S.
60. 60. Randall VA, Thornton MJ, Hamada K Messenger AG. Androgen action in cultured dermal papilla cells from human hair follicles. Skin Pharmacol 1994; 7: 20-6.
61. 61. Itami S, Kurata S, Sonoda T, Takayasu S. Mechanism of action of androgen in dermal papilla cells. Ann N Y Acad Sci 1991; 642: 385-95.
62. 62. Itami S, Kurata S, Sonoda T, Takayasu S. Characterization of 5 alpha-reductase in cultured human dermal papilla cells from beard and occipital scalp hair. J Invest Dermatol 1991; 96: 57-60.
63. 63. Hoffmann R, Happle R. Finasteride is the main inhibitor of 5a-reductase activity in microdissected dermal papillae from human hair follicles. Arch Dermatol Res 1999; 100-3.
64. 64. Thiboutot DM, Knaggs H, Gilliland K, Hagari S. Activity of type 1 5 alpha-reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 1997; 136: 166-71.
65. 65. Sawaya ME, Penneys NS. Immunohistochemical distribution of aromatase and 3B-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland. J Cutan Pathol 1992; 19: 309-14.
66. 66. Ayoub JP, Valero V, Hortobagyi GN. Tamoxifen-induced female androgenetic alopecia in a patient with breast cancer. Ann Intern Med 1997; 126: 745-6.
67. 67. Blauer M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P. Location of androgen receptor in human skin. J Invest Dermatol 1991; 97: 264-8.
68. 68. Diani AR, Mills CJ. Immunocytochemical localization of androgen receptors in the scalp of the stumptail macaque monkey, a model of androgenetic alopecia. J Invest Dermatol 1994; 102: 511-4.
69. 69. Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998; 156: 59-65.
70. 70. Rittmaster RS, Magor KE, Manning AP, Norman RW, Lazier CB. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Mol Endocrinol 1991; 5: 1023-9.
71. 71. George FW, Russell DW, Wilson JD. Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase. Proc Natl Acad Sci U S A 1991; 88: 8044-7.
72. 72. Wahe M, Antonipillai I, Horton R. Effects of transforming growth factor beta and epidermal growth factor on steroid 5 alpha-reductase activity in genital skin fibroblasts. Mol Cell Endocrinol 1993; 98: 55-9.
73. 73. Horton R, Pasupuletti V, Antonipillai I. Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I. Endocrinology 1993; 133: 447-51.
74. 74. Dykstra KD, Payne AM, Abdelrahim M, Francis GL. Insulin-like growth factor I, but not growth hormone, has in vitro proliferative effects on neonatal foreskin fibroblasts without affecting 5-alpha-reductase or androgen receptor activity. J Androl 1993; 14: 73-8.
75. 75. Arai A, von Hintzenstern J, Kiesewetter F, Schell H, Hornstein OP. In vitro effects of testosterone, dihydrotestosterone and estradiol on cell growth of human hair bulb papilla cells and hair root sheath fibroblasts. Acta Derm Venereol 1990; 70: 338-41.
76. 76. Yu DW, Yang T, Sonoda T, Gaffney K, Jensen PJ, Dooley T, Ledbetter S, Freedberg IM, Lavker R, Sun TT. Message of nexin 1, a serine protease inhibitor, is accumulated in the follicular papilla during anagen of the hair cycle. J Cell Sci 1995; 108: 3867-74.
77. 77. Sonoda T, Kurata S, Asada Y, Takayasu S. Message of protease nexin-I is expressed in human dermal papilla cells and is affected by androgens. J Invest Dermatol 1998; 100: 612 (abstr.).
78. 78. Itami S, Sonoda T, Kurata S, Takayasu S. Mechanism of action of androgen in hair follicles. J Dermatol Sci 1994; 7 (suppl.)I: S98-103.
79. 79. Thornton MJ, Hamada K, Messenger AG, Randall VA. Androgen-dependent beard dermal papilla cells secrete autocrine growth factor(s) in response to testosterone unlike scalp cells. J Invest Dermatol 1998; 111: 727-32.
80. 80. Hibberts NA, Messenger AG, Randall VA. Dermal papilla cells derived from beard hair follicles secrete more stem cell factor (SCF) in culture than scalp cells or dermal fibroblasts. Biochem Biophys Res Commun 1996; 222: 401-5.